Multifaceted role of neuropilins in cancer

Current Medicinal Chemistry

Volumn 18, Issue 23, 2011, Pages 3563-3575

  Rizzolio, S ^a   Tamagnone, L ^a  

^a UNIVERSITY OF TURIN   (Italy)

Author keywords

Angiogenesis; Cancer; Metastasis; Neuropilins; Plexins; Semaphorins; Signaling; Targeted therapy

Indexed keywords

NEUROPILIN 1; NEUROPILIN 2; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ANGIOGENESIS; ARTICLE; ASTROCYTOMA; BLADDER CANCER; BREAST CANCER; CANCER CELL; CANCER GROWTH; CELL MIGRATION; COLORECTAL CANCER; DIGESTIVE SYSTEM CANCER; ESOPHAGUS CANCER; GALLBLADDER CANCER; GLIOMA; HUMAN; LUNG NON SMALL CELL CANCER; LYMPHOCYTE; MACROPHAGE; MOLECULAR MECHANICS; NEOPLASM; NONHUMAN; OVARY CARCINOMA; PANCREAS CANCER; PROSTATE CANCER; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN INTERACTION; PROTEIN STRUCTURE; SKIN CANCER;

ANIMALS; HUMANS; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; NEUROPILINS; SEMAPHORINS; SIGNAL TRANSDUCTION; VASCULAR ENDOTHELIAL GROWTH FACTORS;

EID: 80051990644     PISSN: 09298673     EISSN: 1875533X     Source Type: Journal    
DOI: 10.2174/092986711796642544     Document Type: Article

References (181)

1. Kolodkin, A.L.; Levengood, D.V.; Rowe, E.G.; Tai, Y.T.; Giger, R.J.; Ginty, D.D. Neuropilin is a semaphorin III receptor. Cell, 1997, 90, 753-762. (Pubitemid 27357966)
2. Soker, S.; Takashima, S.; Miao, H.Q.; Neufeld, G.; Klagsbrun, M. Neuropilin-1 is expressed by endothelial and tumor cells as an isoform-specific receptor for vascular endothelial growth factor. Cell, 1998, 92, 735-745. (Pubitemid 28155313)
3. Takahashi, T.; Fournier, A.; Nakamura, F.; Wang, L.H.; Murakami, Y.; Kalb, R.G.; Fujisawa, H.; Strittmatter, S.M. Plexin-neuropilin-1 complexes form functional semaphorin-3A receptors. Cell, 1999, 99, 59-69. (Pubitemid 29468630)
4. Tamagnone, L.; Artigiani, S.; Chen, H.; He, Z.; Ming, G.I.; Song, H.; Chedotal, A.; Winberg, M.L.; Goodman, C.S.; Poo, M.; Tessier-Lavigne, M.; Cooglio, P.M. Plexins are a large family of receptors for transmembrane, secreted, and GPI-anchored semaphorins in vertebrates. Cell, 1999, 99, 71-80. (Pubitemid 29468631)
5. Fuh, G.; Garcia, K.C.; de Vos, A.M. The interaction of neuropilin-1 with vascular endothelial growth factor and its receptor flt-1. J Biol Chem, 2000, 275, 26690-26695.
6. Soker, S.; Miao, H.Q.; Nomi, M.; Takashima, S.; Klagsbrun, M. VEGF165 mediates formation of complexes containing VEGFR-2 and neuropilin-1 that enhance VEGF165-receptor binding. J Cell Biochem., 2002, 85, 357-368. (Pubitemid 34274903)
7. Takagi, S.; Kasuya, Y.; Shimizu, M.; Matsuura, T.; Tsuboi, M.; Kawakami, A.; Fujisawa, H. Expression of a cell adhesion molecule, neuropilin, in the developing chick nervous system. Dev. Biol, 1995, 170, 207-222.
8. Takagi, S.; Hirata, T.; Agata, K.; Mochii, M.; Eguchi, G.; Fujisawa, H. The A5 antigen, a candidate for the neuronal recognition molecule, has homologies to complement components and coagulation factors. Neuron, 1991, 7, 295-307.
9. Chen, H.; Chedotal, A.; He, Z.; Goodman, C.S.; Tessier-Lavigne, M. Neuropilin-2, a novel member of the neuropilin family, is a high affinity receptor for the semaphorins Sema E and Sema IV but not Sema III. Neuron, 1997, 19, 547-559. (Pubitemid 27430744)
10. Giger, R.J.; Urquhart, E.R.; Gillespie, S.K.; Levengood, D.V.; Ginty, D.D.; Kolodkin, A.L. Neuropilin-2 is a receptor for semaphorin IV: insight into the structural basis of receptor function and specificity. Neuron, 1998, 21, 1079-1092. (Pubitemid 29018077)
11. Nakamura, F.; Tanaka, M.; Takahashi, T.; Kalb, R.G.; Strittmatter, S.M. Neuropilin-1 extracellular domains mediate semaphorin D/III-induced growth cone collapse. Neuron, 1998, 21, 1093-1100. (Pubitemid 29018078)
12. Renzi, M.J.; Feiner, L.; Koppel, A.M.; Raper, J.A. A dominant negative receptor for specific secreted semaphorins is generated by deleting an extracellular domain from neuropilin-1. J Neurosci., 1999, 19, 7870-7880. (Pubitemid 30225785)
13. Gu, C.; Limberg, B.J.; Whitaker, G.B.; Perman, B.; Leahy, D.J.; Rosenbaum, J.S.; Ginty, D.D.; Kolodkin, A.L. Characterization of neuropilin-1 structural features that confer binding to semaphorin 3A and vascular endothelial growth factor 165. J Biol Chem, 2002, 277, 18069-18076. (Pubitemid 34967620)
14. Gluzman-Poltorak, Z.; Cohen, T.; Herzog, Y.; Neufeld, G. Neuropilin-2 is a receptor for the vascular endothelial growth factor (VEGF) forms VEGF-145 and VEGF-165 [corrected]. J Biol Chem, 2000, 275, 18040-18045.
15. Mamluk, R.; Gechtman, Z.; Kutcher, M.E.; Gasiunas, N.; Gallagher, J.; Klagsbrun, M. Neuropilin-1 binds vascular endothelial growth factor 165, placenta growth factor-2, and heparin via its b1b2 domain. J Biol Chem, 2002, 277, 24818-24825. (Pubitemid 34952014)
16. Geretti, E.; Shimizu, A.; Klagsbrun, M. Neuropilin structure governs VEGF and semaphorin binding and regulates angiogenesis. Angiogenesis., 2008, 11, 31-39.
17. He, Z.; Tessier-Lavigne, M. Neuropilin is a receptor for the axonal chemore-pellent Semaphorin III. Cell, 1997, 90, 739-751. (Pubitemid 27357965)
18. Chen, H.; He, Z.; Bagri, A.; Tessier-Lavigne, M. Semaphorin-neuropilin interactions underlying sympathetic axon responses to class III semaphorins. Neuron, 1998, 21, 1283-1290. (Pubitemid 29022531)
19. Roth, L.; Nasarre, C.; rrig-Grosch, S.; Aunis, D.; Cremel, G.; Hubert, P.; Bagnard, D. Transmembrane domain interactions control biological functions of neuropilin-1. Mol. Biol Cell, 2008, 19, 646-654. (Pubitemid 351272152)
20. Rossignol, M.; Gagnon, M.L.; Klagsbrun, M. Genomic organization of human neuropilin-1 and neuropilin-2 genes: identification and distribution of splice variants and soluble isoforms. Genomics, 2000, 70, 211-222. (Pubitemid 32003398)
21. Cai, H.; Reed, R.R. Cloning and characterization of neuropilin-1- interacting protein: a PSD-95/Dlg/ZO-1 domain-containing protein that interacts with the cytoplasmic domain of neuropilin-1. J Neurosci., 1999, 19, 6519-6527. (Pubitemid 29347451)
22. Gagnon, M.L.; Bielenberg, D.R.; Gechtman, Z.; Miao, H.Q.; Takashima, S.; Soker, S.; Klagsbrun, M. Identification of a natural soluble neuropilin-1 that binds vascular endothelial growth factor: In vivo expression and antitumor activity. Proc Natl. Acad. Sci. U. S. A, 2000, 97, 2573-2578. (Pubitemid 30159212)
23. Cackowski, F.C.; Xu, L.; Hu, B.; Cheng, S.Y. Identification of two novel alternatively spliced Neuropilin-1 isoforms. Genomics, 2004, 84, 82-94. (Pubitemid 38760132)
24. Takahashi, T.; Nakamura, F.; Jin, Z.; Kalb, R.G.; Strittmatter, S.M. Semaphorins A and E act as antagonists of neuropilin-1 and agonists of neuropilin-2 receptors. Nat Neurosci., 1998, 1, 487-493.
25. Feiner, L.; Koppel, A.M.; Kobayashi, H.; Raper, J.A. Secreted chick semaphorins bind recombinant neuropilin with similar affinities but bind different subsets of neurons in situ. Neuron, 1997, 19, 539-545. (Pubitemid 27430743)
26. Cheng, H.J.; Bagri, A.; Yaron, A.; Stein, E.; Pleasure, S.J.; Tessier-Lavigne, M. Plexin-A3 mediates semaphorin signaling and regulates the development of hippocampal axonal projections. Neuron, 2001, 32, 249-263. (Pubitemid 33030193)
27. Yaron, A.; Huang, P.H.; Cheng, H.J.; Tessier-Lavigne, M. Differential requirement for Plexin-A3 and -A4 in mediating responses of sensory and sympathetic neurons to distinct class 3 Semaphorins. Neuron, 2005, 45, 513-523. (Pubitemid 40249864)
28. Pan, Q.; Chathery, Y.; Wu, Y.; Rathore, N.; Tong, R.K.; Peale, F.; Bagri, A.; Tessier-Lavigne, M.; Koch, A.W.; Watts, R.J. Neuropilin-1 binds to VEGF121 and regulates endothelial cell migration and sprouting. J Biol Chem, 2007, 282, 24049-24056. (Pubitemid 47328044)
29. Wise, L.M.; Veikkola, T.; Mercer, A.A.; Savory, L.J.; Fleming, S.B.; Caesar, C.; Vitali, A.; Makinen, T.; Alitalo, K.; Stacker, S.A. Vascular endothelial growth factor (VEGF)-like protein from orf virus NZ2 binds to VEGFR2 and neuropilin-1. Proc Natl. Acad. Sci. U. S. A, 1999, 96, 3071-3076. (Pubitemid 29148845)
30. Makinen, T.; Olofsson, B.; Karpanen, T.; Hellman, U.; Soker, S.; Klagsbrun, M.; Eriksson, U.; Alitalo, K. Differential binding of vascular endothelial growth factor B splice and proteolytic isoforms to neuropilin-1. J Biol Chem, 1999, 274, 21217-21222.
31. Migdal, M.; Huppertz, B.; Tessler, S.; Comforti, A.; Shibuya, M.; Reich, R.; Baumann, H.; Neufeld, G. Neuropilin-1 is a placenta growth factor-2 receptor. J Biol Chem, 1998, 273, 22272-22278. (Pubitemid 28399784)
32. Karpanen, T.; Heckman, C.A.; Keskitalo, S.; Jeltsch, M.; Ollila, H.; Neufeld, G.; Tamagnone, L.; Alitalo, K. Functional interaction of VEGF-C and VEGF-D with neuropilin receptors. F A S E B J, 2006, 20, 1462-1472. (Pubitemid 44943854)
33. Narazaki, M.; Tosato, G. Ligand-induced internalization selects use of common receptor neuropilin-1 by VEGF165 and semaphorin3A. Blood, 2006, 107, 3892-3901. (Pubitemid 43726793)
34. Appleton, B.A.; Wu, P.; Maloney, J.; Yin, J.; Liang, W.C.; Stawicki, S.; Mortara, K.; Bowman, K.K.; Elliott, J.M.; Desmarais, W.; Bazan, J.F.; Bagri, A.; Tessier-Lavigne, M.; Koch, A.W.; Wu, Y.; Watts, R.J.; Wiesmann, C. Structural studies of neuropilin/antibody complexes provide insights into semaphorin and VEGF binding. EMBO J, 2007, 26, 4902-4912. (Pubitemid 350191304)
35. Prahst, C.; Heroult, M.; Lanahan, A.A.; Uziel, N.; Kessler, O.; Shraga-Heled, N.; Simons, M.; Neufeld, G.; Augustin, H.G. Neuropilin-1-VEGFR-2 complexing requires the PDZ-binding domain of neuropilin-1. J Biol Chem, 2008, 283, 25110-25114.
36. Wang, L.; Zeng, H.; Wang, P.; Soker, S.; Mukhopadhyay, D. Neuropilin-1-mediated vascular permeability factor/vascular endothelial growth factor-dependent endothelial cell migration. J Biol Chem, 2003, 278, 48848-48860.
37. Wang, L.; Dutta, S.K.; Kojima, T.; Xu, X.; Khosravi-Far, R.; Ekker, S.C.; Mukhopadhyay, D. Neuropilin-1 modulates p53/caspases axis to promote endothelial cell survival. PLoS. One., 2007, 2, e1161
38. Wang, L.; Mukhopadhyay, D.; Xu, X. C terminus of RGS-GAIP-interacting protein conveys neuropilin-1-mediated signaling during angiogenesis. FASEB J, 2006, 20, 1513-1515.
39. Hermans, K.; Claes, F.; Vandevelde, W.; Zheng, W.; Geudens, I.; Orsenigo, F.; De, S.F.; Gjini, E.; Anthonis, K.; Ren, B.; Kerjaschki, D.; Autiero, M.; Ny, A.; Simons, M.; Dewerchin, M.; Schulte-Merker, S.; Dejana, E.; Alitalo, K.; Carmeliet, P. Role of synectin in lymphatic development in zebrafish and frogs. Blood, 2010, 116, 3356-3366.
40. Bachelder, R.E.; Lipscomb, E.A.; Lin, X.; Wendt, M.A.; Chadborn, N.H.; Eickholt, B.J.; Mercurio, A.M. Competing autocrine pathways involving alternative neuropilin-1 ligands regulate chemotaxis of carcinoma cells. Cancer Res, 2003, 63, 5230-5233. (Pubitemid 37139833)
41. Geretti, E.; van Meeteren, L.A.; Shimizu, A.; Dudley, A.C.; Claesson-Welsh, L.; Klagsbrun, M. A mutated soluble neuropilin-2 B domain antagonizes vascular endothelial growth factor bioactivity and inhibits tumor progression. Mol. Cancer Res, 2010, 8, 1063-1073.
42. Zhang, S.; Zhau, H.E.; Osunkoya, A.O.; Iqbal, S.; Yang, X.; Fan, S.; Chen, Z.; Wang, R.; Marshall, F.F.; Chung, L.W.; Wu, D. Vascular endothelial growth factor regulates myeloid cell leukemia-1 expression through neuropilin-1-dependent activation of c-MET signaling in human prostate cancer cells. Mol. Cancer, 2010, 9, 9
43. Salikhova, A.; Wang, L.; Lanahan, A.A.; Liu, M.; Simons, M.; Leenders, W.P.; Mukhopadhyay, D.; Horowitz, A. Vascular endothelial growth factor and semaphorin induce neuropilin-1 endocytosis via separate pathways. Circ. Res, 2008, 103, e71-e79.
44. Narazaki, M.; Segarra, M.; Hou, X.; Tanaka, T.; Li, X.; Tosato, G. Oligoguanosinenucleotide induces neuropilin-1 internalization in endothelial cells and inhibits angiogenesis. Blood, 2010,
45. Narazaki, M.; Segarra, M.; Tosato, G. Sulfated polysaccharides identified as inducers of neuropilin-1 internalization and functional inhibition of VEGF165 and semaphorin3A. Blood, 2008, 111, 4126-4136.
46. Bae, D.; Lu, S.; Taglienti, C.A.; Mercurio, A.M. Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2. J Biol Chem, 2008, 283, 28074-28080.
47. Valdembri, D.; Caswell, P.T.; Anderson, K.I.; Schwarz, J.P.; Konig, I.; Astanina, E.; Caccavari, F.; Norman, J.C.; Humphries, M.J.; Bussolino, F.; Serini, G. Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS. Biol, 2009, 7, e25
48. Shimizu, M.; Murakami, Y.; Suto, F.; Fujisawa, H. Determination of cell adhesion sites of neuropilin-1. J Cell Biol, 2000, 148, 1283-1293.
49. Murga, M.; Fernandez-Capetillo, O.; Tosato, G. Neuropilin-1 regulates attachment in human endothelial cells independently of vascular endothelial growth factor receptor-2. Blood, 2005, 105, 1992-1999. (Pubitemid 40731783)
50. Robinson, S.D.; Reynolds, L.E.; Kostourou, V.; Reynolds, A.R.; da Silva, R.G.; Tavora, B.; Baker, M.; Marshall, J.F.; Hodivala-Dilke, K.M. Alphav beta3 integrin limits the contribution of neuropilin-1 to vascular endothelial growth factor-induced angiogenesis. J Biol Chem, 2009, 284, 33966-33981.
51. Falk, J.; Bechara, A.; Fiore, R.; Nawabi, H.; Zhou, H.; Hoyo-Becerra, C.; Bozon, M.; Rougon, G.; Grumet, M.; Puschel, A.W.; Sanes, J.R.; Castellani, V. Dual functional activity of semaphorin 3B is required for positioning the anterior commissure. Neuron, 2005, 48, 63-75. (Pubitemid 41384166)
52. Castellani, V.; De, A.E.; Kenwrick, S.; Rougon, G. Cis and trans interactions of L1 with neuropilin-1 control axonal responses to semaphorin 3A. EMBO J, 2002, 21, 6348-6357. (Pubitemid 35448413)
53. Stoeck, A.; Schlich, S.; Issa, Y.; Gschwend, V.; Wenger, T.; Herr, I.; Marme, A.; Bourbie, S.; Altevogt, P.; Gutwein, P. L1 on ovarian carcinoma cells is a binding partner for Neuropilin-1 on mesothelial cells. Cancer Lett., 2006, 239, 212-226. (Pubitemid 43974866)
54. Neufeld, G.; Cohen, T.; Shraga, N.; Lange, T.; Kessler, O.; Herzog, Y. The neuropilins: multifunctional semaphorin and VEGF receptors that modulate axon guidance and angiogenesis. Trends Cardiovasc. Med., 2002, 12, 13-19. (Pubitemid 34048706)
55. Serini, G.; Valdembri, D.; Zanivan, S.; Morterra, G.; Burkhardt, C.; Caccavari, F.; Zammataro, L.; Primo, L.; Tamagnone, L.; Logan, M.; Tessier-Lavigne, M.; Taniguchi, M.; Puschel, A.W.; Bussolino, F. Class 3 semaphorins control vascular morphogenesis by inhibiting integrin function. Nature, 2003, 424, 391-397. (Pubitemid 36917481)
56. Bagri, A.; Tessier-Lavigne, M.; Watts, R.J. Neuropilins in tumor biology. Clin Cancer Res, 2009, 15, 1860-1864.
57. Chen, H.; Bagri, A.; Zupicich, J.A.; Zou, Y.; Stoeckli, E.; Pleasure, S.J.; Lowenstein, D.H.; Skarnes, W.C.; Chedotal, A.; Tessier-Lavigne, M. Neuropilin-2 regulates the development of selective cranial and sensory nerves and hippocampal mossy fiber projections. Neuron, 2000, 25, 43-56. (Pubitemid 30316509)
58. Kitsukawa, T.; Shimizu, M.; Sanbo, M.; Hirata, T.; Taniguchi, M.; Bekku, Y.; Yagi, T.; Fujisawa, H. Neuropilin-semaphorin III/D-mediated chemorepulsive signals play a crucial role in peripheral nerve projection in mice. Neuron, 1997, 19, 995-1005. (Pubitemid 27512361)
59. Chedotal, A.; Del Rio, J.A.; Ruiz, M.; He, Z.; Borrell, V.; de, C.F.; Ezan, F.; Goodman, C.S.; Tessier-Lavigne, M.; Sotelo, C.; Soriano, E. Semaphorins III and IV repel hippocampal axons via two distinct receptors. Development, 1998, 125, 4313-4323. (Pubitemid 28528938)
60. Bagnard, D.; Lohrum, M.; Uziel, D.; Puschel, A.W.; Bolz, J. Semaphorins act as attractive and repulsive guidance signals during the development of cortical projections. Development, 1998, 125, 5043-5053. (Pubitemid 29026785)
61. Polleux, F.; Giger, R.J.; Ginty, D.D.; Kolodkin, A.L.; Ghosh, A. Patterning of cortical efferent projections by semaphorin-neuropilin interactions. Science, 1998, 282, 1904-1906. (Pubitemid 28555272)
62. Kawasaki, T.; Kitsukawa, T.; Bekku, Y.; Matsuda, Y.; Sanbo, M.; Yagi, T.; Fujisawa, H. A requirement for neuropilin-1 in embryonic vessel formation. Development, 1999, 126, 4895-4902.
63. Kitsukawa, T.; Shimono, A.; Kawakami, A.; Kondoh, H.; Fujisawa, H. Overexpression of a membrane protein, neuropilin, in chimeric mice causes anomalies in the cardiovascular system, nervous system and limbs. Development, 1995, 121, 4309-4318. (Pubitemid 26007578)
64. Gerhardt, H.; Ruhrberg, C.; Abramsson, A.; Fujisawa, H.; Shima, D.; Betsholtz, C. Neuropilin-1 is required for endothelial tip cell guidance in the developing central nervous system. Dev. Dyn., 2004, 231, 503-509. (Pubitemid 39410884)
65. Mukouyama, Y.S.; Gerber, H.P.; Ferrara, N.; Gu, C.; Anderson, D.J. Peripheral nerve-derived VEGF promotes arterial differentiation via neuropilin 1-mediated positive feedback. Development, 2005, 132, 941-952. (Pubitemid 40484929)
66. Gu, C.; Rodriguez, E.R.; Reimert, D.V.; Shu, T.; Fritzsch, B.; Richards, L.J.; Kolodkin, A.L.; Ginty, D.D. Neuropilin-1 conveys semaphorin and VEGF signaling during neural and cardiovascular development. Dev. Cell, 2003, 5, 45-57. (Pubitemid 36827341)
67. Yuan, L.; Moyon, D.; Pardanaud, L.; Breant, C.; Karkkainen, M.J.; Alitalo, K.; Eichmann, A. Abnormal lymphatic vessel development in neuropilin 2 mutant mice. Development, 2002, 129, 4797-4806. (Pubitemid 35282411)
68. Takashima, S.; Kitakaze, M.; Asakura, M.; Asanuma, H.; Sanada, S.; Tashiro, F.; Niwa, H.; Miyazaki, J.J.; Hirota, S.; Kitamura, Y.; Kitsukawa, T.; Fujisawa, H.; Klagsbrun, M.; Hori, M. Targeting of both mouse neuropilin-1 and neuropilin-2 genes severely impairs developmental yolk sac and embryonic angiogenesis. Proc Natl. Acad. Sci. U. S. A, 2002, 99, 3657-3662. (Pubitemid 34252162)
69. Feiner, L.; Webber, A.L.; Brown, C.B.; Lu, M.M.; Jia, L.; Feinstein, P.; Mombaerts, P.; Epstein, J.A.; Raper, J.A. Targeted disruption of semaphorin 3C leads to persistent truncus arteriosus and aortic arch interruption. Development, 2001, 128, 3061-3070. (Pubitemid 32825751)
70. Bielenberg, D.R.; Hida, Y.; Shimizu, A.; Kaipainen, A.; Kreuter, M.; Kim, C.C.; Klagsbrun, M. Semaphorin 3F, a chemorepulsant for endothelial cells, induces a poorly vascularized, encapsulated, nonmetastatic tumor phenotype. J Clin Invest, 2004, 114, 1260-1271. (Pubitemid 40385297)
71. Miao, H.Q.; Soker, S.; Feiner, L.; Alonso, J.L.; Raper, J.A.; Klagsbrun, M. Neuropilin-1 mediates collapsin-1/semaphorin III inhibition of endothelial cell motility: functional competition of collapsin-1 and vascular endothelial growth factor-165. J Cell Biol, 1999, 146, 233-242.
72. Guttmann-Raviv, N.; Shraga-Heled, N.; Varshavsky, A.; Guimaraes-Sternberg, C.; Kessler, O.; Neufeld, G. Semaphorin-3A and semaphorin-3F work together to repel endothelial cells and to inhibit their survival by induction of apoptosis. J Biol Chem, 2007, 282, 26294-26305. (Pubitemid 47443814)
73. Kessler, O.; Shraga-Heled, N.; Lange, T.; Gutmann-Raviv, N.; Sabo, E.; Baruch, L.; Machluf, M.; Neufeld, G. Semaphorin-3F is an inhibitor of tumor angiogenesis. Cancer Res, 2004, 64, 1008-1015. (Pubitemid 38176904)
74. Banu, N.; Teichman, J.; Dunlap-Brown, M.; Villegas, G.; Tufro, A. Semaphorin 3C regulates endothelial cell function by increasing integrin activity. FASEB J, 2006, 20, 2150-2152.
75. Moyon, D.; Pardanaud, L.; Yuan, L.; Breant, C.; Eichmann, A. Plasticity of endothelial cells during arterial-venous differentiation in the avian embryo. Development, 2001, 128, 3359-3370. (Pubitemid 32910388)
76. Herzog, Y.; Kalcheim, C.; Kahane, N.; Reshef, R.; Neufeld, G. Differential expression of neuropilin-1 and neuropilin-2 in arteries and veins. Mech. Dev., 2001, 109, 115-119. (Pubitemid 33035924)
77. Favier, B.; Alam, A.; Barron, P.; Bonnin, J.; Laboudie, P.; Fons, P.; Mandron, M.; Herault, J.P.; Neufeld, G.; Savi, P.; Herbert, J.M.; Bono, F. Neuropilin-2 interacts with VEGFR-2 and VEGFR-3 and promotes human endothelial cell survival and migration. Blood, 2006, 108, 1243-1250. (Pubitemid 44232021)
78. Xu, Y.; Yuan, L.; Mak, J.; Pardanaud, L.; Caunt, M.; Kasman, I.; Larrivee, B.; Del, T.R.; Suchting, S.; Medvinsky, A.; Silva, J.; Yang, J.; Thomas, J.L.; Koch, A.W.; Alitalo, K.; Eichmann, A.; Bagri, A. Neuropilin-2 mediates VEGF-C-induced lymphatic sprouting together with VEGFR3. J Cell Biol, 2010, 188, 115-130.
79. Zacchigna, S.; Pattarini, L.; Zentilin, L.; Moimas, S.; Carrer, A.; Sinigaglia, M.; Arsic, N.; Tafuro, S.; Sinagra, G.; Giacca, M. Bone marrow cells recruited through the neuropilin-1 receptor promote arterial formation at the sites of adult neoangiogenesis in mice. J Clin Invest, 2008, 118, 2062-2075. (Pubitemid 351872326)
80. Maione, F.; Molla, F.; Meda, C.; Latini, R.; Zentilin, L.; Giacca, M.; Seano, G.; Serini, G.; Bussolino, F.; Giraudo, E. Semaphorin 3A is an endogenous angiogenesis inhibitor that blocks tumor growth and normalizes tumor vasculature in transgenic mouse models. J Clin Invest, 2009, 119, 3356-3372.
81. Casazza, A.; Fu, X.; Johansson, I.; Capparuccia, L.; Andersson, F.; Giustacchini, A.; Squadrito, M.L.; Venneri, M.A.; Mazzone, M.; Larsson, E.; Carmeliet, P.; De, P.M.; Naldini, L.; Tamagnone, L.; Rolny, C. Systemic and Targeted Delivery of Semaphorin 3A Inhibits Tumor Angiogenesis and Progression in Mouse Tumor Models. Arterioscler. Thromb. Vasc. Biol, 2011,
82. Dallas, N.A.; Gray, M.J.; Xia, L.; Fan, F.; van, B.G.; Gaur, P.; Samuel, S.; Lim, S.J.; Arumugam, T.; Ramachandran, V.; Wang, H.; Ellis, L.M. Neuropilin-2-mediated tumor growth and angiogenesis in pancreatic adenocarcinoma. Clin Cancer Res, 2008, 14, 8052-8060.
83. Pellet-Many, C.; Frankel, P.; Jia, H.; Zachary, I. Neuropilins: structure, function and role in disease. Biochem. J, 2008, 411, 211-226. (Pubitemid 351580173)
84. Marcus, K.; Johnson, M.; Adam, R.M.; O'Reilly, M.S.; Donovan, M.; Atala, A.; Freeman, M.R.; Soker, S. Tumor cell-associated neuropilin-1 and vascular endothelial growth factor expression as determinants of tumor growth in neuroblastoma. Neuropathology., 2005, 25, 178-187. (Pubitemid 41602601)
85. Rieger, J.; Wick, W.; Weller, M. Human malignant glioma cells express semaphorins and their receptors, neuropilins and plexins. Glia, 2003, 42, 379-389. (Pubitemid 36702278)
86. Ellis, L.M. The role of neuropilins in cancer. Mol. Cancer Ther., 2006, 5, 1099-1107. (Pubitemid 43881301)
87. Barr, M.P.; Byrne, A.M.; Duffy, A.M.; Condron, C.M.; Devocelle, M.; Harriott, P.; Bouchier-Hayes, D.J.; Harmey, J.H. A peptide corresponding to the neuropilin-1-binding site on VEGF(165) induces apoptosis of neuropilin-1- expressing breast tumour cells. Br. J Cancer, 2005, 92, 328-333. (Pubitemid 40343149)
88. Bielenberg, D.R.; Pettaway, C.A.; Takashima, S.; Klagsbrun, M. Neuropilins in neoplasms: expression, regulation, and function. Exp. Cell Res, 2006, 312, 584-593. (Pubitemid 43290335)
89. Guttmann-Raviv, N.; Kessler, O.; Shraga-Heled, N.; Lange, T.; Herzog, Y.; Neufeld, G. The neuropilins and their role in tumorigenesis and tumor progression. Cancer Lett., 2006, 231, 1-11. (Pubitemid 41779447)
90. Wey, J.S.; Gray, M.J.; Fan, F.; Belcheva, A.; McCarty, M.F.; Stoeltzing, O.; Somcio, R.; Liu, W.; Evans, D.B.; Klagsbrun, M.; Gallick, G.E.; Ellis, L.M. Overexpression of neuropilin-1 promotes constitutive MAPK signalling and chemoresistance in pancreatic cancer cells. Br. J Cancer, 2005, 93, 233-241. (Pubitemid 41133210)
91. Neufeld, G.; Shraga-Heled, N.; Lange, T.; Guttmann-Raviv, N.; Herzog, Y.; Kessler, O. Semaphorins in cancer. Front Biosci., 2005, 10, 751-760.
92. Vanveldhuizen, P.J.; Zulfiqar, M.; Banerjee, S.; Cherian, R.; Saxena, N.K.; Rabe, A.; Thrasher, J.B.; Banerjee, S.K. Differential expression of neuropilin-1 in malignant and benign prostatic stromal tissue. Oncol Rep., 2003, 10, 1067-1071.
93. Parikh, A.A.; Fan, F.; Liu, W.B.; Ahmad, S.A.; Stoeltzing, O.; Reinmuth, N.; Bielenberg, D.; Bucana, C.D.; Klagsbrun, M.; Ellis, L.M. Neuropilin-1 in human colon cancer: expression, regulation, and role in induction of angiogenesis. Am J Pathol., 2004, 164, 2139-2151. (Pubitemid 38669361)
94. Ghosh, S.; Sullivan, C.A.; Zerkowski, M.P.; Molinaro, A.M.; Rimm, D.L.; Camp, R.L.; Chung, G.G. High levels of vascular endothelial growth factor and its receptors (VEGFR-1, VEGFR-2, neuropilin-1) are associated with worse outcome in breast cancer. Hum. Pathol., 2008, 39, 1835-1843.
95. Hansel, D.E.; Wilentz, R.E.; Yeo, C.J.; Schulick, R.D.; Montgomery, E.; Maitra, A. Expression of neuropilin-1 in high-grade dysplasia, invasive cancer, and metastases of the human gastrointestinal tract. Am J Surg. Pathol., 2004, 28, 347-356. (Pubitemid 38269568)
96. Osada, H.; Tokunaga, T.; Nishi, M.; Hatanaka, H.; Abe, Y.; Tsugu, A.; Kijima, H.; Yamazaki, H.; Ueyama, Y.; Nakamura, M. Overexpression of the neuropilin 1 (NRP1) gene correlated with poor prognosis in human glioma. Anticancer Res, 2004, 24, 547-552. (Pubitemid 38624988)
97. Latil, A.; Bieche, I.; Pesche, S.; Valeri, A.; Fournier, G.; Cussenot, O.; Lidereau, R. VEGF overexpression in clinically localized prostate tumors and neuropilin-1 overexpression in metastatic forms. Int. J Cancer, 2000, 89, 167-171. (Pubitemid 30185926)
98. Hong, T.M.; Chen, Y.L.; Wu, Y.Y.; Yuan, A.; Chao, Y.C.; Chung, Y.C.; Wu, M.H.; Yang, S.C.; Pan, S.H.; Shih, J.Y.; Chan, W.K.; Yang, P.C. Targeting neuropilin 1 as an antitumor strategy in lung cancer. Clin Cancer Res, 2007, 13, 4759-4768. (Pubitemid 47294782)
99. Kreuter, M.; Woelke, K.; Bieker, R.; Schliemann, C.; Steins, M.; Buechner, T.; Berdel, W.E.; Mesters, R.M. Correlation of neuropilin-1 overexpression to survival in acute myeloid leukemia. Leukemia, 2006, 20, 1950-1954. (Pubitemid 44614883)
100. Osada, R.; Horiuchi, A.; Kikuchi, N.; Ohira, S.; Ota, M.; Katsuyama, Y.; Konishi, I. Expression of semaphorins, vascular endothelial growth factor, and their common receptor neuropilins and alleic loss of semaphorin locus in epithelial ovarian neoplasms: increased ratio of vascular endothelial growth factor to semaphorin is a poor prognostic factor in ovarian carcinomas. Hum. Pathol., 2006, 37, 1414-1425. (Pubitemid 44584330)
101. Kawakami, T.; Tokunaga, T.; Hatanaka, H.; Kijima, H.; Yamazaki, H.; Abe, Y.; Osamura, Y.; Inoue, H.; Ueyama, Y.; Nakamura, M. Neuropilin 1 and neuropilin 2 co-expression is significantly correlated with increased vascularity and poor prognosis in nonsmall cell lung carcinoma. Cancer, 2002, 95, 2196-2201. (Pubitemid 35253382)
102. Fukahi, K.; Fukasawa, M.; Neufeld, G.; Itakura, J.; Korc, M. Aberrant expression of neuropilin-1 and -2 in human pancreatic cancer cells. Clin Cancer Res, 2004, 10, 581-590. (Pubitemid 38173997)
103. Broholm, H.; Laursen, H. Vascular endothelial growth factor (VEGF) receptor neuropilin-1's distribution in astrocytic tumors. APMIS, 2004, 112, 257-263. (Pubitemid 39005907)
104. Ding, H.; Wu, X.; Roncari, L.; Lau, N.; Shannon, P.; Nagy, A.; Guha, A. Expression and regulation of neuropilin-1 in human astrocytomas. Int. J Cancer, 2000, 88, 584-592.
105. Mariani, L.; Beaudry, C.; McDonough, W.S.; Hoelzinger, D.B.; Demuth, T.; Ross, K.R.; Berens, T.; Coons, S.W.; Watts, G.; Trent, J.M.; Wei, J.S.; Giese, A.; Berens, M.E. Glioma cell motility is associated with reduced transcription of proapoptotic and proliferation genes: a cDNA microarray analysis. J Neurooncol., 2001, 53, 161-176. (Pubitemid 33034689)
106. Sanchez-Carbayo, M.; Socci, N.D.; Lozano, J.J.; Li, W.; Charytonowicz, E.; Belbin, T.J.; Prystowsky, M.B.; Ortiz, A.R.; Childs, G.; Cordon-Cardo, C. Gene discovery in bladder cancer progression using cDNA microarrays. Am J Pathol., 2003, 163, 505-516. (Pubitemid 36909413)
107. Yasuoka, H.; Kodama, R.; Tsujimoto, M.; Yoshidome, K.; Akamatsu, H.; Nakahara, M.; Inagaki, M.; Sanke, T.; Nakamura, Y. Neuropilin-2 expression in breast cancer: correlation with lymph node metastasis, poor prognosis, and regulation of CXCR4 expression. BMC Cancer, 2009, 9, 220
108. Cohen, T.; Gluzman-Poltorak, Z.; Brodzky, A.; Meytal, V.; Sabo, E.; Misselevich, I.; Hassoun, M.; Boss, J.H.; Resnick, M.; Shneyvas, D.; Eldar, S.; Neufeld, G. Neuroendocrine cells along the digestive tract express neuropilin-2. Biochem. Biophys. Res Commun., 2001, 284, 395-403. (Pubitemid 32917990)
109. Jogi, A.; Vallon-Christersson, J.; Holmquist, L.; Axelson, H.; Borg, A.; Pahlman, S. Human neuroblastoma cells exposed to hypoxia: induction of genes associated with growth, survival, and aggressive behavior. Exp. Cell Res, 2004, 295, 469-487. (Pubitemid 38490500)
110. Parikh, A.A.; Liu, W.B.; Fan, F.; Stoeltzing, O.; Reinmuth, N.; Bruns, C.J.; Bucana, C.D.; Evans, D.B.; Ellis, L.M. Expression and regulation of the novel vascular endothelial growth factor receptor neuropilin-1 by epidermal growth factor in human pancreatic carcinoma. Cancer, 2003, 98, 720-729. (Pubitemid 36959267)
111. Akagi, M.; Kawaguchi, M.; Liu, W.; McCarty, M.F.; Takeda, A.; Fan, F.; Stoeltzing, O.; Parikh, A.A.; Jung, Y.D.; Bucana, C.D.; Mansfield, P.F.; Hicklin, D.J.; Ellis, L.M. Induction of neuropilin-1 and vascular endothelial growth factor by epidermal growth factor in human gastric cancer cells. Br. J Cancer, 2003, 88, 796-802. (Pubitemid 36411462)
112. Lichtenberger, B.M.; Tan, P.K.; Niederleithner, H.; Ferrara, N.; Petzelbauer, P.; Sibilia, M. Autocrine VEGF signaling synergizes with EGFR in tumor cells to promote epithelial cancer development. Cell, 2010, 140, 268-279.
113. Hsieh, S.H.; Ying, N.W.; Wu, M.H.; Chiang, W.F.; Hsu, C.L.; Wong, T.Y.; Jin, Y.T.; Hong, T.M.; Chen, Y.L. Galectin-1, a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells. Oncogene, 2008, 27, 3746-3753. (Pubitemid 351912963)
114. Yamada, Y.; Oike, Y.; Ogawa, H.; Ito, Y.; Fujisawa, H.; Suda, T.; Takakura, N. Neuropilin-1 on hematopoietic cells as a source of vascular development. Blood, 2003, 101, 1801-1809. (Pubitemid 36237577)
115. Fons, P.; Herault, J.P.; Delesque, N.; Tuyaret, J.; Bono, F.; Herbert, J.M. VEGF-R2 and neuropilin-1 are involved in VEGF-A-induced differentiation of human bone marrow progenitor cells. J Cell Physiol, 2004, 200, 351-359. (Pubitemid 39006926)
116. Tordjman, R.; Ortega, N.; Coulombel, L.; Plouet, J.; Romeo, P.H.; Lemarchandel, V. Neuropilin-1 is expressed on bone marrow stromal cells: a novel interaction with hematopoietic cells? Blood, 1999, 94, 2301-2309. (Pubitemid 29467678)
117. Pucci, F.; Venneri, M.A.; Biziato, D.; Nonis, A.; Moi, D.; Sica, A.; Di, S.C.; Naldini, L.; De, P.M. A distinguishing gene signature shared by tumorinfiltrating Tie2-expressing monocytes, blood "resident" monocytes, and embryonic macrophages suggests common functions and developmental relationships. Blood, 2009, 114, 901-914.
118. Tordjman, R.; Lepelletier, Y.; Lemarchandel, V.; Cambot, M.; Gaulard, P.; Hermine, O.; Romeo, P.H. A neuronal receptor, neuropilin-1, is essential for the initiation of the primary immune response. Nat Immunol., 2002, 3, 477-482. (Pubitemid 34520798)
119. Curreli, S.; Arany, Z.; Gerardy-Schahn, R.; Mann, D.; Stamatos, N.M. Polysialylated neuropilin-2 is expressed on the surface of human dendritic cells and modulates dendritic cell-T lymphocyte interactions. J Biol Chem, 2007, 282, 30346-30356. (Pubitemid 350035196)
120. Catalano, A.; Caprari, P.; Moretti, S.; Faronato, M.; Tamagnone, L.; Procopio, A. Semaphorin-3A is expressed by tumor cells and alters T-cell signal transduction and function. Blood, 2006, 107, 3321-3329.
121. Lepelletier, Y.; Moura, I.C.; Hadj-Slimane, R.; Renand, A.; Fiorentino, S.; Baude, C.; Shirvan, A.; Barzilai, A.; Hermine, O. Immunosuppressive role of semaphorin-3A on T cell proliferation is mediated by inhibition of actin cytoskeleton reorganization. Eur. J Immunol., 2006, 36, 1782-1793. (Pubitemid 44089045)
122. Lepelletier, Y.; Lecourt, S.; Renand, A.; Arnulf, B.; Vanneaux, V.; Fermand, J.P.; Menasche, P.; Domet, T.; Marolleau, J.P.; Hermine, O.; Larghero, J. Galectin-1 and semaphorin-3A are two soluble factors conferring T-cell immunosuppression to bone marrow mesenchymal stem cell. Stem Cells Dev., 2010, 19, 1075-1079.
123. Bruder, D.; Probst-Kepper, M.; Westendorf, A.M.; Geffers, R.; Beissert, S.; Loser, K.; von, B.H.; Buer, J.; Hansen, W. Neuropilin-1: a surface marker of regulatory T cells. Eur. J Immunol., 2004, 34, 623-630. (Pubitemid 39255909)
124. Battaglia, A.; Buzzonetti, A.; Monego, G.; Peri, L.; Ferrandina, G.; Fanfani, F.; Scambia, G.; Fattorossi, A. Neuropilin-1 expression identifies a subset of regulatory T cells in human lymph nodes that is modulated by preoperative chemoradiation therapy in cervical cancer. Immunology, 2008, 123, 129-138. (Pubitemid 350256004)
125. Battaglia, A.; Buzzonetti, A.; Baranello, C.; Ferrandina, G.; Martinelli, E.; Fanfani, F.; Scambia, G.; Fattorossi, A. Metastatic tumour cells favour the generation of a tolerogenic milieu in tumour draining lymph node in patients with early cervical cancer. Cancer Immunol. Immunother., 2009, 58, 1363-1373.
126. Glinka, Y.; Prud'homme, G.J. Neuropilin-1 is a receptor for transforming growth factor beta-1, activates its latent form, and promotes regulatory T cell activity. J Leukoc. Biol, 2008, 84, 302-310. (Pubitemid 351960305)
127. Bachelder, R.E.; Crago, A.; Chung, J.; Wendt, M.A.; Shaw, L.M.; Robinson, G.; Mercurio, A.M. Vascular endothelial growth factor is an autocrine survival factor for neuropilin-expressing breast carcinoma cells. Cancer Res, 2001, 61, 5736-5740. (Pubitemid 32769088)
128. Baba, T.; Kariya, M.; Higuchi, T.; Mandai, M.; Matsumura, N.; Kondoh, E.; Miyanishi, M.; Fukuhara, K.; Takakura, K.; Fujii, S. Neuropilin-1 promotes unlimited growth of ovarian cancer by evading contact inhibition. Gynecol. Oncol, 2007, 105, 703-711. (Pubitemid 46734196)
129. Ochiumi, T.; Kitadai, Y.; Tanaka, S.; Akagi, M.; Yoshihara, M.; Chayama, K. Neuropilin-1 is involved in regulation of apoptosis and migration of human colon cancer. Int. J Oncol, 2006, 29, 105-116.
130. Miao, H.Q.; Lee, P.; Lin, H.; Soker, S.; Klagsbrun, M. Neuropilin-1 expression by tumor cells promotes tumor angiogenesis and progression. FASEB J, 2000, 14, 2532-2539.
131. Lu, L.; Zhang, L.; Xiao, Z.; Lu, S.; Yang, R.; Han, Z.C. Neuropilin-1 in acute myeloid leukemia: expression and role in proliferation and migration of leukemia cells. Leuk. Lymphoma, 2008, 49, 331-338. (Pubitemid 351193927)
132. Bachelder, R.E.; Wendt, M.A.; Mercurio, A.M. Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4. Cancer Res, 2002, 62, 7203-7206. (Pubitemid 36025239)
133. Hu, B.; Guo, P.; Bar-Joseph, I.; Imanishi, Y.; Jarzynka, M.J.; Bogler, O.; Mikkelsen, T.; Hirose, T.; Nishikawa, R.; Cheng, S.Y. Neuropilin-1 promotes human glioma progression through potentiating the activity of the HGF/SF autocrine pathway. Oncogene, 2007, 26, 5577-5586. (Pubitemid 47267840)
134. Cao, Y.; Wang, L.; Nandy, D.; Zhang, Y.; Basu, A.; Radisky, D.; Mukhopadhyay, D. Neuropilin-1 upholds dedifferentiation and propagation pheno-types of renal cell carcinoma cells by activating Akt and sonic hedgehog axes. Cancer Res, 2008, 68, 8667-8672.
135. Kamiya, T.; Kawakami, T.; Abe, Y.; Nishi, M.; Onoda, N.; Miyazaki, N.; Oida, Y.; Yamazaki, H.; Ueyama, Y.; Nakamura, M. The preserved expression of neuropilin (NRP) 1 contributes to a better prognosis in colon cancer. Oncol Rep., 2006, 15, 369-373.
136. Gray, M.J.; Wey, J.S.; Belcheva, A.; McCarty, M.F.; Trevino, J.G.; Evans, D.B.; Ellis, L.M.; Gallick, G.E. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Cancer Res, 2005, 65, 3664-3670. (Pubitemid 40616343)
137. Handa, A.; Tokunaga, T.; Tsuchida, T.; Lee, Y.H.; Kijima, H.; Yamazaki, H.; Ueyama, Y.; Fukuda, H.; Nakamura, M. Neuropilin-2 expression affects the increased vascularization and is a prognostic factor in osteosarcoma. Int. J Oncol, 2000, 17, 291-295.
138. Gray, M.J.; van, B.G.; Dallas, N.A.; Xia, L.; Wang, X.; Yang, A.D.; Somcio, R.J.; Lin, Y.G.; Lim, S.; Fan, F.; Mangala, L.S.; Arumugam, T.; Logsdon, C.D.; Lopez-Berestein, G.; Sood, A.K.; Ellis, L.M. Therapeutic targeting of neuropilin-2 on colorectal carcinoma cells implanted in the murine liver. J Natl. Cancer Inst., 2008, 100, 109-120. (Pubitemid 351480563)
139. Caunt, M.; Mak, J.; Liang, W.C.; Stawicki, S.; Pan, Q.; Tong, R.K.; Kowalski, J.; Ho, C.; Reslan, H.B.; Ross, J.; Berry, L.; Kasman, I.; Zlot, C.; Cheng, Z.; Le, C.J.; Filvaroff, E.H.; Plowman, G.; Peale, F.; French, D.; Carano, R.; Koch, A.W.; Wu, Y.; Watts, R.J.; Tessier-Lavigne, M.; Bagri, A. Blocking neuropilin-2 function inhibits tumor cell metastasis. Cancer Cell, 2008, 13, 331-342. (Pubitemid 351446192)
140. Kim, W.H.; Lee, S.H.; Jung, M.H.; Seo, J.H.; Kim, J.; Kim, M.A.; Lee, Y.M. Neuropilin2 expressed in gastric cancer endothelial cells increases the proliferation and migration of endothelial cells in response to VEGF. Exp. Cell Res, 2009, 315, 2154-2164.
141. Catalano, A.; Caprari, P.; Rodilossi, S.; Betta, P.; Castellucci, M.; Casazza, A.; Tamagnone, L.; Procopio, A. Cross-talk between vascular endothelial growth factor and semaphorin-3A pathway in the regulation of normal and malignant mesothelial cell proliferation. FASEB J, 2004, 18, 358-360.
142. Tomizawa, Y.; Sekido, Y.; Kondo, M.; Gao, B.; Yokota, J.; Roche, J.; Drabkin, H.; Lerman, M.I.; Gazdar, A.F.; Minna, J.D. Inhibition of lung cancer cell growth and induction of apoptosis after reexpression of 3p21.3 candidate tumor suppressor gene SEMA3B. Proc Natl. Acad. Sci. U. S. A, 2001, 98, 13954-13959. (Pubitemid 33116005)
143. Kuroki, T.; Trapasso, F.; Yendamuri, S.; Matsuyama, A.; Alder, H.; Williams, N.N.; Kaiser, L.R.; Croce, C.M. Allelic loss on chromosome 3p21.3 and promoter hypermethylation of semaphorin 3B in non-small cell lung cancer. Cancer Res, 2003, 63, 3352-3355. (Pubitemid 36735894)
144. Futamura, M.; Kamino, H.; Miyamoto, Y.; Kitamura, N.; Nakamura, Y.; Ohnishi, S.; Masuda, Y.; Arakawa, H. Possible role of semaphorin 3F, a candidate tumor suppressor gene at 3p21.3, in p53-regulated tumor angiogenesis suppression. Cancer Res, 2007, 67, 1451-1460. (Pubitemid 46383370)
145. Ochi, K.; Mori, T.; Toyama, Y.; Nakamura, Y.; Arakawa, H. Identification of semaphorin3B as a direct target of p53. Neoplasia., 2002, 4, 82-87. (Pubitemid 34075893)
146. Castro-Rivera, E.; Ran, S.; Brekken, R.A.; Minna, J.D. Semaphorin 3B inhibits the phosphatidylinositol 3-kinase/Akt pathway through neuropilin-1 in lung and breast cancer cells. Cancer Res, 2008, 68, 8295-8303.
147. Castro-Rivera, E.; Ran, S.; Thorpe, P.; Minna, J.D. Semaphorin 3B (SEMA3B) induces apoptosis in lung and breast cancer, whereas VEGF165 antagonizes this effect. Proc Natl. Acad. Sci. U. S. A, 2004, 101, 11432-11437. (Pubitemid 39038364)
148. Rolny, C.; Capparuccia, L.; Casazza, A.; Mazzone, M.; Vallario, A.; Cignetti, A.; Medico, E.; Carmeliet, P.; Comoglio, P.M.; Tamagnone, L. The tumor suppressor semaphorin 3B triggers a prometastatic program mediated by interleukin 8 and the tumor microenvironment. J Exp. Med., 2008, 205, 1155-1171. (Pubitemid 351679690)
149. Lantuejoul, S.; Constantin, B.; Drabkin, H.; Brambilla, C.; Roche, J.; Brambilla, E. Expression of VEGF, semaphorin SEMA3F, and their common receptors neuropilins NP1 and NP2 in preinvasive bronchial lesions, lung tumours, and cell lines. J Pathol., 2003, 200, 336-347. (Pubitemid 36827308)
150. Nasarre, P.; Constantin, B.; Rouhaud, L.; Harnois, T.; Raymond, G.; Drabkin, H.A.; Bourmeyster, N.; Roche, J. Semaphorin SEMA3F and VEGF have opposing effects on cell attachment and spreading. Neoplasia., 2003, 5, 83-92. (Pubitemid 36151061)
151. Potiron, V.A.; Sharma, G.; Nasarre, P.; Clarhaut, J.A.; Augustin, H.G.; Gemmill, R.M.; Roche, J.; Drabkin, H.A. Semaphorin SEMA3F affects multiple signaling pathways in lung cancer cells. Cancer Res, 2007, 67, 8708-8715. (Pubitemid 47437446)
152. Yamada, T.; Endo, R.; Gotoh, M.; Hirohashi, S. Identification of semaphorin E as a non-MDR drug resistance gene of human cancers. Proc Natl. Acad. Sci. U. S. A, 1997, 94, 14713-14718. (Pubitemid 28041439)
153. Casazza, A.; Finisguerra, V.; Capparuccia, L.; Camperi, A.; Swiercz, J.M.; Rizzolio, S.; Rolny, C.; Christensen, C.; Bertotti, A.; Sarotto, I.; Risio, M.; Trusolino, L.; Weitz, J.; Schneider, M.; Mazzone, M.; Comoglio, P.M.; Tamagnone, L. Sema3E-Plexin D1 signaling drives human cancer cell invasiveness and metastatic spreading in mice. J Clin Invest, 2010, 120, 2684-2698.
154. Christensen, C.R.; Klingelhofer, J.; Tarabykina, S.; Hulgaard, E.F.; Kramerov, D.; Lukanidin, E. Transcription of a novel mouse semaphorin gene, MsemaH, correlates with the metastatic ability of mouse tumor cell lines. Cancer Res, 1998, 58, 1238-1244. (Pubitemid 28183214)
155. Martin-Satue, M.; Blanco, J. Identification of semaphorin E gene expression in metastatic human lung adenocarcinoma cells by mRNA differential display. J Surg. Oncol, 1999, 72, 18-23. (Pubitemid 29446936)
156. Roodink, I.; Kats, G.; van, K.L.; Grunberg, M.; Maass, C.; Verrijp, K.; Raats, J.; Leenders, W. Semaphorin 3E expression correlates inversely with Plexin D1 during tumor progression. Am J Pathol., 2008, 173, 1873-1881.
157. Chauvet, S.; Cohen, S.; Yoshida, Y.; Fekrane, L.; Livet, J.; Gayet, O.; Segu, L.; Buhot, M.C.; Jessell, T.M.; Henderson, C.E.; Mann, F. Gating of Sema3E/PlexinD1 signaling by neuropilin-1 switches axonal repulsion to attraction during brain development. Neuron, 2007, 56, 807-822. (Pubitemid 350181350)
158. Fukasawa, M.; Matsushita, A.; Korc, M. Neuropilin-1 interacts with integrin beta1 and modulates pancreatic cancer cell growth, survival and invasion. Cancer Biol Ther., 2007, 6, 1173-1180. (Pubitemid 351590368)
159. Sulpice, E.; Plouet, J.; Berge, M.; Allanic, D.; Tobelem, G.; Merkulova-Rainon, T. Neuropilin-1 and neuropilin-2 act as coreceptors, potentiating proangiogenic activity. Blood, 2008, 111, 2036-2045. (Pubitemid 351451514)
160. Matsushita, A.; Gotze, T.; Korc, M. Hepatocyte growth factor-mediated cell invasion in pancreatic cancer cells is dependent on neuropilin-1. Cancer Res, 2007, 67, 10309-10316. (Pubitemid 350070805)
161. Glinka, Y.; Stoilova, S.; Mohammed, N.; Prud'homme, G.J. Neuropilin-1 exerts coreceptor function for TGF-beta-1 on the membrane of cancer cells and enhances responses to both latent and active TGF-beta. Carcinogenesis, 2010,
162. West, D.C.; Rees, C.G.; Duchesne, L.; Patey, S.J.; Terry, C.J.; Turnbull, J.E.; Delehedde, M.; Heegaard, C.W.; Allain, F.; Vanpouille, C.; Ron, D.; Fernig, D.G. Interactions of multiple heparin binding growth factors with neuropilin-1 and potentiation of the activity of fibroblast growth factor-2. J Biol Chem, 2005, 280, 13457-13464. (Pubitemid 40517234)
163. Banerjee, S.; Sengupta, K.; Dhar, K.; Mehta, S.; D'Amore, P.A.; Dhar, G.; Banerjee, S.K. Breast cancer cells secreted platelet-derived growth factorinduced motility of vascular smooth muscle cells is mediated through neuropilin-1. Mol. Carcinog., 2006, 45, 871-880. (Pubitemid 44646339)
164. Ball, S.G.; Bayley, C.; Shuttleworth, C.A.; Kielty, C.M. Neuropilin-1 regulates platelet-derived growth factor receptor signalling in mesenchymal stem cells. Biochem. J, 2010, 427, 29-40.
165. Dhar, K.; Dhar, G.; Majumder, M.; Haque, I.; Mehta, S.; Van Veldhuizen, P.J.; Banerjee, S.K.; Banerjee, S. Tumor cell-derived PDGF-B potentiates mouse mesenchymal stem cells-pericytes transition and recruitment through an interaction with NRP-1. Mol. Cancer, 2010, 9, 209
166. Neufeld, G.; Kessler, O. The semaphorins: versatile regulators of tumour progression and tumour angiogenesis. Nat Rev Cancer, 2008, 8, 632-645.
167. Xu, L.; Duda, D.G.; di, T.E.; Ancukiewicz, M.; Chung, D.C.; Lauwers, G.Y.; Samuel, R.; Shellito, P.; Czito, B.G.; Lin, P.C.; Poleski, M.; Bentley, R.; Clark, J.W.; Willett, C.G.; Jain, R.K. Direct evidence that bevacizumab, an anti-VEGF antibody, up-regulates SDF1alpha, CXCR4, CXCL6, and neuropilin 1 in tumors from patients with rectal cancer. Cancer Res, 2009, 69, 7905-7910.
168. Pan, Q.; Chanthery, Y.; Liang, W.C.; Stawicki, S.; Mak, J.; Rathore, N.; Tong, R.K.; Kowalski, J.; Yee, S.F.; Pacheco, G.; Ross, S.; Cheng, Z.; Le, C.J.; Plowman, G.; Peale, F.; Koch, A.W.; Wu, Y.; Bagri, A.; Tessier-Lavigne, M.; Watts, R.J. Blocking neuropilin-1 function has an additive effect with anti-VEGF to inhibit tumor growth. Cancer Cell, 2007, 11, 53-67. (Pubitemid 46054517)
169. Starzec, A.; Vassy, R.; Martin, A.; Lecouvey, M.; Di, B.M.; Crepin, M.; Perret, G.Y. Antiangiogenic and antitumor activities of peptide inhibiting the vascular endothelial growth factor binding to neuropilin-1. Life Sci., 2006, 79, 2370-2381. (Pubitemid 44772930)
170. Jia, H.; Cheng, L.; Tickner, M.; Bagherzadeh, A.; Selwood, D.; Zachary, I. Neuropilin-1 antagonism in human carcinoma cells inhibits migration and enhances chemosensitivity. Br. J Cancer, 2010, 102, 541-552.
171. Mac, G.F.; Popel, A.S. Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches. PLoS. Comput. Biol, 2006, 2, e180
172. Liang, W.C.; Dennis, M.S.; Stawicki, S.; Chanthery, Y.; Pan, Q.; Chen, Y.; Eigenbrot, C.; Yin, J.; Koch, A.W.; Wu, X.; Ferrara, N.; Bagri, A.; Tessier-Lavigne, M.; Watts, R.J.; Wu, Y. Function blocking antibodies to neuropilin-1 generated from a designed human synthetic antibody phage library. J Mol. Biol, 2007, 366, 815-829. (Pubitemid 46175863)
173. Nasarre, C.; Roth, M.; Jacob, L.; Roth, L.; Koncina, E.; Thien, A.; Labourdette, G.; Poulet, P.; Hubert, P.; Cremel, G.; Roussel, G.; Aunis, D.; Bagnard, D. Peptide-based interference of the transmembrane domain of neuropilin-1 inhibits glioma growth in vivo. Oncogene, 2010, 29, 2381-2392.
174. Yamada, Y.; Takakura, N.; Yasue, H.; Ogawa, H.; Fujisawa, H.; Suda, T. Exogenous clustered neuropilin 1 enhances vasculogenesis and angiogenesis. Blood, 2001, 97, 1671-1678. (Pubitemid 32217232)
175. Schuch, G.; Machluf, M.; Bartsch, G., Jr.; Nomi, M.; Richard, H.; Atala, A.; Soker, S. In vivo administration of vascular endothelial growth factor (VEGF) and its antagonist, soluble neuropilin-1, predicts a role of VEGF in the progression of acute myeloid leukemia in vivo. Blood, 2002, 100, 4622-4628. (Pubitemid 35429707)
176. Uniewicz, K.A.; Cross, M.J.; Fernig, D.G. Exogenous recombinant dimeric neuropilin-1 is sufficient to drive angiogenesis. J Biol Chem, 2011, 286, 12-23.
177. Geretti, E.; Shimizu, A.; Kurschat, P.; Klagsbrun, M. Site-directed mutagenesis in the B-neuropilin-2 domain selectively enhances its affinity to VEGF165, but not to semaphorin 3 F. J Biol Chem, 2007, 282, 25698-25707. (Pubitemid 47372796)
178. Merte, J.; Wang, Q.; Vander Kooi, C.W.; Sarsfield, S.; Leahy, D.J.; Kolodkin, A.L.; Ginty, D.D. A forward genetic screen in mice identifies Sema3A(K108N), which binds to neuropilin-1 but cannot signal. J Neurosci., 2010, 30, 5767-5775.
179. Li, M.; Yang, H.; Chai, H.; Fisher, W.E.; Wang, X.; Brunicardi, F.C.; Yao, Q.; Chen, C. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Cancer, 2004, 101, 2341-2350. (Pubitemid 39458692)
180. Qi, L.; Robinson, W.A.; Brady, B.M.; Glode, L.M. Migration and invasion of human prostate cancer cells is related to expression of VEGF and its receptors. Anticancer Res, 2003, 23, 3917-3922. (Pubitemid 37474343)
181. Straume, O.; Akslen, L.A. Increased expression of VEGF-receptors (FLT-1, KDR, NRP-1) and thrombospondin-1 is associated with glomeruloid microvascular proliferation, an aggressive angiogenic phenotype, in malignant melanoma. Angiogenesis., 2003, 6, 295-301. (Pubitemid 38987539)